LABS Stock Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally.
MediPharm Labs Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.08|
|52 Week High||CA$0.23|
|52 Week Low||CA$0.06|
|1 Month Change||14.29%|
|3 Month Change||6.67%|
|1 Year Change||-57.90%|
|3 Year Change||-97.65%|
|5 Year Change||n/a|
|Change since IPO||-96.36%|
Recent News & Updates
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) OutlookAug 20
Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) EstimatesMay 21
Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's DowngradeApr 06
Is MediPharm Labs (TSE:LABS) Using Too Much Debt?Mar 07
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?Aug 18
Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's EstimatesMay 23
Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last YearJan 11
|LABS||CA Pharmaceuticals||CA Market|
Return vs Industry: LABS underperformed the Canadian Pharmaceuticals industry which returned -46.8% over the past year.
Return vs Market: LABS underperformed the Canadian Market which returned -3.4% over the past year.
|LABS Average Weekly Movement||13.6%|
|Pharmaceuticals Industry Average Movement||14.6%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||18.4%|
|10% least volatile stocks in CA Market||4.1%|
Stable Share Price: LABS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: LABS's weekly volatility (14%) has been stable over the past year.
About the Company
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services.
MediPharm Labs Corp. Fundamentals Summary
|LABS fundamental statistics|
Is LABS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LABS income statement (TTM)|
|Cost of Revenue||CA$27.79m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.16|
|Net Profit Margin||-207.43%|
How did LABS perform over the long term?See historical performance and comparison